Novavax Announces Participation in Two Booster Studies Using its COVID-19 Vaccine

U.S. NIAID-sponsored trial will evaluate heterologous booster regimens, including NVX-CoV2373, after primary series with current FDA approved or emergency use authorized-vaccines